Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-10 7:00 pm Purchase | 2025-03-06 | 13D | Oruka Therapeutics, Inc. ORKA | Fairmount Funds Management LLC | 8,511,824 19.990% | 570,134 (+7.18%) | Filing History |
| 2025-02-14 3:45 pm Purchase | 2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Fairmount Funds Management LLC | 7,018,575 9.900% | 398,264 (+6.02%) | Filing History |
| 2025-02-14 3:45 pm Unchanged | 2024-12-31 | 13G | Enliven Therapeutics, Inc. ELVN | Fairmount Funds Management LLC | 3,202,798 6.600% | 0 (Unchanged) | Filing History |
| 2025-02-14 3:45 pm Purchase | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 5,869,037 9.900% | 992 (+0.02%) | Filing History |
| 2025-02-14 3:45 pm Sale | 2024-12-31 | 13G | AnaptysBio, Inc. ANAB | Fairmount Funds Management LLC | 0 0.000% | -1,671,484 (Position Closed) | Filing History |
| 2025-02-14 3:45 pm Sale | 2024-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Fairmount Funds Management LLC | 0 0.000% | -3,204,841 (Position Closed) | Filing History |
| 2024-12-18 4:30 pm Purchase | 2024-12-11 | 13G | AnaptysBio, Inc. ANAB | Fairmount Funds Management LLC | 1,671,484 5.500% | 1,671,484 (New Position) | Filing History |
| 2024-11-21 6:30 pm Purchase | 2024-11-19 | 13D | Oruka Therapeutics, Inc. ORKA | Fairmount Funds Management LLC | 7,941,690 19.990% | 17 (+0.00%) | Filing History |
| 2024-11-14 4:15 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 0 0.000% | -6,632,015 (Position Closed) | Filing History |
| 2024-11-14 4:15 pm Purchase | 2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Fairmount Funds Management LLC | 3,204,841 7.900% | 3,204,841 (New Position) | Filing History |
| 2024-11-14 4:15 pm Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 5,868,045 9.900% | 2,234,080 (+61.48%) | Filing History |
| 2024-11-14 4:15 pm Purchase | 2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN | Fairmount Funds Management LLC | 3,202,798 6.800% | 1,071,429 (+50.27%) | Filing History |
| 2024-10-17 7:00 pm Purchase | 2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT | Fairmount Funds Management LLC | 6,620,311 9.900% | 6,620,311 (New Position) | Filing History |
| 2024-09-17 9:00 pm Purchase | 2024-09-13 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 15,556,685 17.950% | 1,600,000 (+11.46%) | Filing History |
| 2024-09-13 4:57 pm Purchase | 2024-09-11 | 13D | Oruka Therapeutics, Inc. ORKA | Fairmount Funds Management LLC | 7,941,673 19.990% | 1,330,418 (+20.12%) | Filing History |
| 2024-09-06 5:08 pm Purchase | 2024-08-29 | 13D | Oruka Therapeutics, Inc. ORKA | Fairmount Funds Management LLC | 6,611,255 19.990% | 6,611,255 (New Position) | Filing History |
| 2024-06-13 06:06 am Purchase | 2024-06-11 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 11,330,141 9.900% | 1,343,585 (+13.45%) | Filing History |
| 2024-04-25 4:40 pm Purchase | 2024-04-23 | 13D | Spyre Therapeutics, Inc. SYRE | Fairmount Funds Management LLC | 4,508,579 11.170% | 3,672,120 (+439.01%) | Filing History |
| 2024-04-01 6:38 pm Unchanged | 2024-03-28 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 13,956,685 18.640% | 0 (Unchanged) | Filing History |
| 2024-04-01 6:34 pm Sale | 2024-04-01 | 13D | Dianthus Therapeutics, Inc. DNTH | Fairmount Funds Management LLC | 2,957,385 9.990% | -3,362 (-0.11%) | Filing History |